GIC
BNTX icon

Generali Investments CEE’s BioNTech BNTX Stock Holding History

Generali Investments CEE’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Hold
3,200
– – 0.01% 397
2026
Q1 		$284K Hold
3,200
– – 0.01% 397
2025
Q4 		$305K Hold
3,200
– – 0.02% 342
2025
Q3 		$316K Hold
3,200
– – 0.02% 326
2025
Q2 		$341K Buy
3,200
+2,000
+167% +$202K 0.03% 310
2025
Q1 		$109K Hold
1,200
– – 0.01% 354
2024
Q4 		$137K Buy
+1,200
New +$137K 0.01% 317

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Generali Investments CEE's BNTX Position: Q2 2026 in Review

Generali Investments CEE held its BioNTech (BNTX) position steady in Q2 2026 at 3,200 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #397.

Generali Investments CEE first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $341K in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Generali Investments CEE held 3,200 shares of BioNTech worth $298K as of Q2 2026.
  • Generali Investments CEE left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up 0.01% of Generali Investments CEE's portfolio in Q2 2026, its #397 holding.
  • Generali Investments CEE first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's BioNTech position peaked at $341K in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.